PolyPeptide Group AG
SIX:PPGN
Operating Margin
PolyPeptide Group AG
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CH |
|
PolyPeptide Group AG
SIX:PPGN
|
752.3m CHF |
-2%
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
994.4B USD |
15%
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
182.1B USD |
18%
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
145.1B USD |
20%
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW |
32%
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
40.3B CHF |
15%
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
278B CNY |
27%
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.5B USD |
23%
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
32.1B USD |
14%
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.2B USD |
29%
|
|
| IN |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1.8T INR |
28%
|
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on PolyPeptide Group AG's most recent financial statements, the company has Operating Margin of -1.7%.
You don't have any saved screeners yet